Prime Medicine (PRME) Other Non-Current Assets (2021 - 2026)

Prime Medicine's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $1.0 million for Q1 2026.

• Quarterly Other Non-Current Assets fell 92.89% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 92.89% YoY) and the FY2025 annual result came in at $13.7 million, down 2.64% from the prior year.
• Other Non-Current Assets was $1.0 million for Q1 2026 at Prime Medicine, down from $13.7 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $14.1 million in Q3 2024 and bottomed at $1.0 million in Q1 2026.
• A 5-year average of $12.9 million and a median of $13.5 million in 2022 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets gained 4.19% — and 2026, when it plunged 92.89%.
• Prime Medicine's Other Non-Current Assets stood at $13.5 million in 2022, then changed by 0.0% to $13.5 million in 2023, then advanced by 4.19% to $14.1 million in 2024, then decreased by 2.64% to $13.7 million in 2025, then tumbled by 92.7% to $1.0 million in 2026.
• Business Quant data shows PRME's Other Non-Current Assets at $1.0 million in Q1 2026, $13.7 million in Q4 2025, and $13.7 million in Q3 2025.